Sign Up Today and Learn More About Lyra Health Stock
Invest in or calculate the value of your shares in Lyra Health or other pre-IPO companies through EquityZen's platform.
About Lyra Health Stock
Founded
2015
Headquarters
Burlingame, CA, US
Notable Investor
IVP (Institutional Venture Partners)
Industries
Lyra helps companies improve access to effective, high-quality mental health care for their employees. Lyra's matching technology and innovative digital platform connect members to a curated network of top therapists and coaches, which results in 3x more people receiving care and 7x better outcomes than traditional plans and EAPs. Members can find the right personalized care, match with the right provider for their needs, and feel motivated and supported throughout the entire treatment journey.
Lyra Health Press Mentions
Stay in the know about the latest news on Lyra Health
Lyra Health Convenes Global Human Resources Leaders to Promote Workforce Mental Health at Breakthrough 2024
finance • Jun 24, 2024
New Four-Year Study: Lyra Health Delivers First and Only Sustained Medical Cost Reductions Due to Mental Health ...
businesswire • Jun 24, 2024
Lyra Health Introduces Lyra Care for Teens
finance • Jun 24, 2024
Lyra Health enhances its mental health platform with advanced data management
siliconangle • Jun 10, 2024
Lyra Health Announces Mental Health Offering for Teens
medcitynews • May 26, 2024
Investors in Lyra Health
Discover investors in Lyra Health stock and explore their portfolio companies
Lyra Health Management
Leadership team at Lyra Health
Chief Executive Officer
David Ebersman
Chief Medical Officer
Connie Chen
Join now and verify your accreditation status to gain access to:
- Lyra Health current valuation
- Lyra Health stock price
- Available deals in Lyra Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Lyra Health stock?
Accredited investors can buy pre-IPO stock in companies like Lyra Health through EquityZen funds. These investments are made available by existing Lyra Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lyra Health stock?
Shareholders can sell their Lyra Health stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
